[Cancer pain management. Basic therapy and treatment of breakthrough pain].
Cancer pain imposes a great burden on patients and results in considerable constraints limiting their quality of life. The basic treatment for chronic pain consists in oral administration of long-acting preparations of various analgesic agents according to a set schedule. In addition to chronic pain, however, about 60% of cancer patients also suffer from breakthrough pain. Rapid-onset and short-acting preparations of highly potent opioids are available for the management of these attacks. To choose the correct analgesic agent, it is essential to take a comprehensive medical history and be aware of the different forms of pain present.
Nauck
F
F
Abteilung Palliativmedizin, Georg-August-Universität Göttingen,Universitätsmedizin Göttingen, Deutschland. Friedemann.Nauck@med.uni-goettingen.de
Eulitz
N
N
D000284:Administration, Oral; D000285:Administration, Rectal; D000286:Administration, Sublingual; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000700:Analgesics / Q000008:administration & dosage / Q000627:therapeutic use*; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000008:administration & dosage / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage / Q000627:therapeutic use; D002908:Chronic Disease; D004164:Diphosphonates / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D009369:Neoplasms / Q000503:physiopathology*; D010146:Pain / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology; D059408:Pain Management; D010147:Pain Measurement; D013997:Time Factors; D014944:World Health Organization
D000305:Adrenal Cortex Hormones; D000700:Analgesics; D000701:Analgesics, Opioid; D000927:Anticonvulsants; D000929:Antidepressive Agents, Tricyclic; D004164:Diphosphonates